Drug receptor Interactions - lecture 6 Flashcards

1
Q

Name the 5 main models to explain the effects of partial agonists, full agonists and antagonsists.

A

Occupancy Model, Rate Model, Induction Model, Perturbation Model and Cooperativity Model.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Occupancy Model

A

The intensity of pharmacological effect is directly proportional to the number of receptor binding sites occupied by the drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Rate Model

A

The intensity of pharmacological effect is directly proportional to the total number of encounters of the drug with its receptor binding sites per unit time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Induction Model

A

The pharmacological effect is induced by the drug through specific conformational changes in the active binding site of the receptor complex.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Perturbation Model

A

Pharmacological substances induce macromolecular perturbations, agonist trigger relatively specific conformational changes as compared to antagonists.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cooperativity Model

A

If pharmacological receptors exist in a dynamic equilibrium between activated and inactive states, agonists may shift the equilibrium to an active state and antagonists to an inactive state.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How many receptor super-families are there and what do they provide?

A
  • 4 receptors
  • Provides a useful framework for interpreting most drug-receptor interactions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the type 1 receptors and give an example.

A

Ionotropic receptor
- Ligand-gated ion channel receptor
- example: nAChR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the components of the Ligand-gated ion channel

A
  • Ligand binding domain
  • Ion channel lining domain
  • Membrane-spanning domain
    > Hydrophobic a-helical region
    > approx. 20 AAs long
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How many subunits are formed together to result in a ion channel complex?

A

five

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Characteristics of type 1 receptors?

A
  • Extremely fast response (milliseconds)
  • Membrane-bound
  • Direct coupling to ion channel
  • Oligomeric assembly of subunits surrounding central ion pore.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the type 2 receptors and give an example.

A

Metabotropic receptor
- G-protein coupled receptor
- example: mAChR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the components of the type 2 receptors

A
  • Ligand binding domains
  • G-protein coupling domain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Characteristics of type 2 receptors?

A
  • fast response (seconds)
  • membrane-bound
  • indirect coupling via G-protein to effector (enzyme or ion channel)
  • monomeric assembly comprising of seven trans-membrane helices.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the type 3 receptors and give an example.

A

Kinase-linked receptor
- Cytokine receptor
-example: Insulin-R

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the components of the type 3 receptors

A
  • Extracellular Ligand binding domain
  • Intracellular, Catalytic domain, Kinase activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Characteristics of type 3 receptors?

A
  • slow response (hours)
    -membrane-bound
  • direct coupling to enzyme
  • single trans-membrane helix
  • direct linkage between receptor and kinase enzyme.
18
Q

What are the type 4 receptors and give an example.

A

Nuclear receptor
- example: Steroid-R

19
Q

Describe the components of the type 4 receptors

A
  • Receptor binding domain
  • ‘Zinc-fingers’ DNA-binding domain
20
Q

Characteristics of type 4 receptors?

A
  • slow response (hours)
  • intracellular
  • coupling via DNA
  • effect on gene transcription
  • monomeric structure with separate receptor and DNA binding domains
21
Q

What are the types of nuclear receptors?

A

Class I, Hybrid Class and Class II

22
Q

Class 1 of nuclear receptors characteristics and examples?

A
  • present in cytoplasm
  • operate as homodimers
  • mainly endocrine ligands
  • high affinity
    examples: GR, MR, ER and PR
23
Q

Hybrid Class characteristics and examples?

A
  • mainly endocrine
  • operates as RXR heterodimers
    examples: TR, VDR
24
Q

Class II characteristics and examples?

A
  • present in nucleus
  • operate as heterodimers (except RXR)
  • mainly lipid ligands
  • low affinity
    examples: PPAR, LXR, FXR and RXR
25
Q

What is the agonist for the nAChR receptor?

A

Nicotine

26
Q

Nicotine

A
  • alkaloid from tobacco plants
  • Agonist of nicotinic acetylcholine receptor
  • stimulating drug (Parasympathomimetic)
  • potential toxic side effects
27
Q

What is the agonist for the beta-adrenoreceptor receptor?

A

Isoprenaline

28
Q

Isoprenaline

A
  • B-adrenergic agonist
  • structural similarity to adrenaline
  • treatment of slow heart rate (Bradycardia)
29
Q

What is the modulator for the ion channel: Voltage-dep. Na+ - channel?

A

Lidocaine

30
Q

Lidocaine

A
  • local anaesthetic
  • common usage: injected for dental anesthesia and minor surgery, topical form relieves skin inflammation.
31
Q

What is the agonist for the Voltage-dep. Ca2+ - channel?

A

Nifedipine

32
Q

Nifedipine

A
  • Dihydropyridine
  • L-type calcium channel blocker
  • Usage:
    > anti-anginal drug
    > antihypertensive agent
33
Q

What is the inhibitor for the enzyme: Acetylcholinesterase?

A

Neostigmine

34
Q

Neostigmine

A
  • Reversible inhibitor of acetylcholinesterase
  • Interference with the breakdown of physiological ligand
  • Indirect stimulation of nicotine and muscarinic receptors
  • usage:
    > Reversal of the effected of non-depolarising muscle relxants following anaesthesia
    > Treatment of myasthenia gravis to increase NMJ stimulation.
35
Q

What is the inhibitor for the enzyme Cyclooxygenase?

A

Aspirin

36
Q

Aspirin

A
  • Non-steroidal anti-inflammatory drug (NSAID)
  • Inhibitor of the enzyme cyclooxygenase (COX-1>COX-2)
  • Usage:
    > Analgesic
    > Anti-platelet drug
37
Q

What is the inhibitor for the choline carrier?

A

Hemicholinium

38
Q

Hemicholinium

A
  • blocks choline uptake
  • not used clinically
  • neuromuscular blocking drug
39
Q

What is the inhibitor for the Na+/K+- pump?

A

Ouabain

40
Q

Ouabain

A
  • Cardiac glycoside
  • Blocker of Na+/K+ - ATPase
  • Increases (Ca2+)i due to decreased NCX
  • Therapeutic usage in heart failure
  • Potential toxicity